BNP/CALL/NOVO-NORDISK B/750/0.1/20.12.24 Share Price

Warrant

DE000PC367N6

Real-time Boerse Frankfurt Warrants 15:21:12 04/07/2024 BST
3.32 EUR -0.90% Intraday chart for BNP/CALL/NOVO-NORDISK B/750/0.1/20.12.24
Current month-12.30%
1 month+17.13%
Date Price Change
04/07/24 3.32 -0.90%
03/07/24 3.35 -2.05%
02/07/24 3.42 -7.32%
01/07/24 3.69 -3.40%
28/06/24 3.82 +2.41%

Real-time Boerse Frankfurt Warrants

Last update July 04, 2024 at 03:21 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC367N
ISINDE000PC367N6
Date issued 30/01/2024
Strike 750 kr
Maturity 20/12/2024 (169 Days)
Parity 10 : 1
Emission price 1.02
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.99
Lowest since issue 1.35
Delta0x
Omega 0.000000
Premium0x
Gearing3.88x
Moneyness 1.293
Difference Strike -220 kr
Difference Strike %-29.33%
Spread 0.04
Spread %1.19%
Intrinsic value 2.947
Present value 0.4031

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
967.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-1.59%
Consensus